Zepbound 5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FF1E1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,337
Award facts
- Contract value 100% obligated
- $8,337.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $8,337.48 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 20, 2026, for the supply of Zepbound 5 mg/0.5 mL pens with a completion date of January 21, 2026. The award was issued on a non-set-aside, competitive basis and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a comprehensive global pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026, which enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., operates as a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. The company's extensive federal contract portfolio encompasses a wide spectrum of pharmaceutical products across multiple therapeutic domains, delivered through firm fixed-price delivery orders and purchase orders. The Zepbound supply under this delivery order supports the Defense Health Agency and other federal healthcare customers requiring diabetes management medications as part of the Defense Logistics Agency's medical supply chain operations.
Quick answers
Who was awarded contract SPE2DR26FF1E1?
SPE2DR26FF1E1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26FF1E1 worth?
The government has obligated $8,337 on SPE2DR26FF1E1.
Is contract SPE2DR26FF1E1 an order under another contract?
Yes. SPE2DR26FF1E1 is a delivery order under SPE2DR25D2005, an indefinite delivery contract.
Was contract SPE2DR26FF1E1 competed?
The extent of competition for SPE2DR26FF1E1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award